抗獨特型抗體（Anti-idiotype antibody, Anti-ID Abs）是針對抗體可變區的抗原決定簇（獨特型）產生的特異性抗體?？躬毺匦涂贵w可作為免疫原性（Immunogenicity）分析的重要參照，也被廣泛用于臨床前研究和臨床開發中抗體藥物含量的測定（包括：游離型、結合型和總量），是藥代動力學（PK）和藥效動力學（PD）分析的重要試劑。
隨著仿制藥的出現，使得患者能夠享用負擔得起的創新藥。GenScript生產出各種類型的針對重磅藥物的抗獨特型抗體，助力仿制藥的研發。
抗獨特型抗體（Anti-idiotype antibody, Anti-ID Abs）的應用
- 抗體藥物的藥代動力學（PK）和藥效動力學（PD）分析
- 免疫原性分析：配體中和試驗和抗體阻斷試驗的對照
- 配對的抗獨特型抗體，可用于Sandwich ELISA檢測
- 檢測范圍廣，濃度結果準
- MonoRab™ 單克隆抗體檢測靈敏度可達皮摩爾量級
MonoRab™兔抗Pembrolizumab單克隆抗體(克隆ID：90G12F8)（貨號：A01853）親和力 Kd < 10-12M
為了支持上述研究，GenScript公司開發了一系列高親和力、高特異性的抗獨特型抗體（Anti-idiotype antibody, Anti-ID Abs），可測量游離型和結合型抗體，加速藥物研發的進程。
| 類型 | 抗原阻斷 | 非阻斷 |
|---|---|---|
| 原理圖 |  |
 |
| 特性 | 抗體結合區特異性 | 非抗體結合區特異性 |
| 抗原結合性 | 抑制性或中和性 | 無抑制性 |
| 應用 | 檢測游離型的抗體 | 檢測結合型的抗體 |
- 抗阿達木單抗（Anti-Adalimumab/Humira， 靶向TNF-α）
- 抗依那西普單抗(Anti-Etanercept/Enbrel, 靶向 ?TNF-α)
- 抗納武單抗（Anti-Nivolumab/Opdivo，靶向PD-1）
- 抗阿特朱單抗 （Anti-Atezolizumab/Tecentriq，靶向PD-L1）
- 抗貝伐單抗（Anti-Bevacizumab/Avastin，靶向VEGF）
- 抗雷珠單抗（Anti-Ranibizumab/Lucentis, 靶向VEGF）
- 抗奧濱尤妥珠單抗（Anti-Obinutuzumab/Gazyva，靶向CD20）
- 抗利妥昔單抗（Anti-Rituximab/Rituxan，靶向CD20）
- 抗度普利尤單抗(Anti-Dupilumab/Dupixent, 靶向IL-4Rα)
- 抗烏司奴單抗(Anti-Ustekinumab/Stelara, 靶向IL-12 & ?IL-23)
- 抗達雷木單抗（Anti-Daratumumab/Darzalex ,靶向CD38）
- 抗奧馬珠單抗(Anti-Omalizumab/Xolair, 靶向human IgE)
- 抗狄諾塞麥單抗(Anti-Denosumab/Prolia, 靶向 ?RANKL)
- 抗英夫利昔單抗 （ Anti-Infliximab/Remicade,靶向TNF-α）
- 抗戈利木單抗(Anti-Golimumab/Simponi, 靶向 ?TNF-α)
- 抗派姆單抗（Anti-Pembrolizumab/Keytruda，靶向PD-1）
- 抗阿維魯單抗(Anti-Avelumab/Bavencio, 靶向PD-L1)
- 抗伊匹單抗（Anti-Ipilimumab/Yervoy，靶向CTLA-4）
- 抗西妥昔單抗（Anti-Cetuximab/Erbitux，靶向EGFR）
- 抗帕尼單抗(Anti-Panitumumab/Vectibix, 靶向 ?EGFR)
- 抗曲妥珠單抗（Anti-Trastuzumab/Herceptin, 靶向HER2）
- 抗帕利珠單抗(Anti-Palivizumab/Synagis, 靶向RSV F)
- 抗托株單抗（Anti-Tocilizumab/Actemra，靶向IL-6R）
- 抗抗炎藥單抗（Anti-Sarilumab/Kevzara, 靶向IL-6R）
- 抗德瓦魯單抗（Anti-Durvalumab/Imfinzi, 靶向CD274)
- 抗依庫珠單抗(Anti-Eculizumab/Soliris, 靶向Complement protein C5)
抗阿達木單抗（Anti-Adalimumab, 靶向TNF-α）
| 產品編號 | 名稱 | 半抑制率 IC50（μg/ml） | 應用推薦 |
|---|---|---|---|
| A01954-40 | Anti-Adalimumab Antibody (15C7), mAb, Mouse | 0.258 | Indirect/Inhibitory ELISA, Capture antibody for Adalimumab PK/PD bridging ELISA with A01955-40 |
| A01955-40 | Anti-Adalimumab Antibody (3C2), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Adalimumab, PK/PD bridging ELISA with A01954-40 |
| A01956-40 | Anti-Adalimumab Antibody (3C2) [Biotin], mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Adalimumab, PK/PD bridging ELISA with A01954-40 |
| A01886-40 | Anti-Adalimumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
| A01922-40 | MonoRab™ Anti-Adalimumab Antibody (134D5), mAb, Rabbit | 0.353 | Direct/Inhibitory ELISA, Detection antibody for Adalimumab, PK/PD bridging ELISA with A01921-40 |
| A01923-40 | MonoRab™ Anti-Adalimumab Antibody (196F3), mAb, Rabbit | Non-inhibitory | Direct ELISA, Immunogenicity assay |
| A01921-40 | MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit | 0.175 | Indirect/Inhibitory ELISA, Capture antibody for Adalimumab PK/PD bridging ELISA with A01922-40 |
抗阿特朱單抗 （Anti-Atezolizumab,靶向PD-L1）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01948-40 | Anti-Atezolizumab Antibody (10G9), mAb, Mouse | 0.118 | Indirect/Inhibitory ELISA, Capture antibody for Atezolizumab PK/PD bridging ELISA with A01949-40 |
| A01949-40 | Anti-Atezolizumab Antibody (6B12), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Atezolizumab, PK/PD bridging ELISA with A01948-40 |
| A01950-40 | Anti-Atezolizumab Antibody (6B12) [Biotin], mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Atezolizumab, PK/PD bridging ELISA with A01948-40 |
抗貝伐單抗（Anti-Bevacizumab，靶向VEGF）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01975-40 | Anti-Bevacizumab Antibody (4H1), mAb, Mouse | N/A | Indirect/Inhibitory ELISA, Capture antibody for Bevacizumab PK/PD bridging ELISA with A01976-40 |
| A01976-40 | Anti-Bevacizumab Antibody (6C3), mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Bevacizumab, PK/PD bridging ELISA with A01975-40 |
| A01977-40 | Anti-Bevacizumab Antibody (6C3)[Biotin], mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Bevacizumab, PK/PD bridging ELISA with A01975-40 |
| A01887-40 | Anti-Bevacizumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
| A01895-40 | MonoRab™ Anti-Bevacizumab Antibody (30E1), mAb, Rabbit | Non-inhibitory | Indirect ELISA, Capture antibody for Bevacizumab, PK/PD bridging ELISA with A01896-40 |
| A01962-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3), mAb, Rabbit | 0.046 | Direct/Inhibitory ELISA, Detection antibody for Bevacizumab, PK/PD bridging ELISA with A01895-40 |
| A01896-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3)[Biotin], mAb, Rabbit | 0.04616 | Direct/Inhibitory ELISA, Detection antibody for Bevacizumab, PK/PD bridging ELISA with A01895-40 |
抗西妥昔單抗（Anti-Cetuximab，靶向EGFR）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01938-40 | Anti-Cetuximab Antibody (18D5), mAb, Mouse | 0.2073 | Direct/Inhibitory ELISA, Detection antibody for Cetuximab, PK/PD bridging ELISA with A01939-40 |
| A01939-40 | Anti-Cetuximab Antibody (20H1), mAb, Mouse | Non-inhibitory | Indirect ELISA, Capture antibody for Cetuximab, PK/PD bridging ELISA with A01938-40 |
抗達雷木單抗（Anti-Daratumumab/Darzalex , 靶向CD38)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01996-40 | Anti-Daratumumab Antibody (11F2), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Capture antibody for Daratumumab, PK/PD bridging ELISA with A01997-40 |
| A01997-40 | Anti-Daratumumab Antibody (6A3), mAb, Mouse | 0.582 | Direct/Indirect/Inhibitory ELISA, Detection antibody for Daratumumab, PK/PD bridging ELISA with A01996-40 |
| A01998-40 | Anti-Daratumumab Antibody (9A6), mAb, Mouse | 0.118 | Direct/Inhibitory ELISA |
| A02009-40 | MonoRab? Anti-Daratumumab(139B10), mAb, Rabbit | 0.017 | Direct/Inhibitory ELISA |
抗德瓦魯單抗（Anti-Durvalumab/Imfinzi, 靶向CD274)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02029-40 | Anti-Durvalumab Antibody (7B6), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Capture antibody for Durvalumab, PK/PD bridging ELISA with A02030-40 |
| A02030-40 | Anti-Durvalumab Antibody (4B5), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Durvalumab, PK/PD bridging ELISA with A02029-40 |
| A02031-40 | Anti-Durvalumab Antibody (15D6), mAb, Mouse | 1.37 | Direct/Inhibitory ELISA |
| A02010-40 | Anti-Durvalumab Antibody, pAb, Rabbit | N/A | Direct ELISA,Immunogenicity assay |
抗伊匹單抗（Anti-Ipilimumab，靶向CTLA-4）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01859-40 | Anti-Ipilimumab Antibody(26B6H7D9), mAb, Mouse | Non-inhibitory | Indirect ELISA, Capture antibody for Ipilimumab, PK/PD bridging ELISA with A01858-40 |
| A01961-40 | Anti-Ipilimumab Antibody (4H6), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Ipilimumab, PK/PD bridging ELISA with A01859-40 |
| A01858-40 | Anti-Ipilimumab Antibody (4H6E1D4)[Biotin], mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Ipilimumab, PK/PD bridging ELISA with A01859-40 |
抗納武單抗（Anti-Nivolumab，靶向PD-1）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01847-40 | Anti-Nivolumab Antibody(8G6G3D8), mAb, Mouse | Non-inhibitory | Indirect ELISA, Capture antibody for Nivolumab, PK/PD bridging ELISA with A01848-40 |
| A01965-40 | Anti-Nivolumab Antibody (6G5), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Nivolumab, PK/PD bridging ELISA with A01847-40 |
| A01848-40 | Anti-Nivolumab Antibody(6G5H2E6)[Biotin], mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Nivolumab, PK/PD bridging ELISA with A01847-40 |
| A01931-40 | Anti-Nivolumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗奧濱尤妥珠單抗（Anti-Obinutuzumab，靶向CD20）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) |
應用推薦 |
|---|---|---|---|
| A01945-40 | Anti-Obinutuzumab Antibody (18H8), mAb, Mouse | N/A | Indirect ELISA, Capture antibody for Obinutuzumab PK/PD bridging ELISA with A01946-40 |
| A01946-40 | Anti-Obinutuzumab Antibody (16B7), mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Obinutuzumab, PK/PD bridging ELISA with A01945-40 |
| A01947-40 | Anti-Obinutuzumab Antibody (16B7) [Biotin], mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Obinutuzumab, PK/PD bridging ELISA with A01945-40 |
| A01933-40 | Anti-Obinutuzumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
| A01966-40 | MonoRab™ Anti-Obinutuzumab Antibody (8G12), mAb, Rabbit | N/A | Indirect ELISA, Capture antibody for Obinutuzumab PK/PD bridging ELISA with A01967-40 |
| A01967-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10), mAb, Rabbit | N/A | Direct/Indirect ELISA, Detection antibody for Obinutuzumab, PK/PD bridging ELISA with A01966-40 |
| A01968-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10) [Biotin], mAb, Rabbit | N/A | Direct/Indirect ELISA, Detection antibody for Obinutuzumab, PK/PD bridging ELISA with A01966-40 |
抗派姆單抗（Anti-Pembrolizumab，靶向PD-1）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01844-40 | Anti-Pembrolizumab Antibody(1D6E10), mAb, Mouse | Non-inhibitory | Indirect ELISA, Capture antibody for pembrolizumab, PK/PD bridging ELISA with A01845 |
| A01845-40 | Anti-Pembrolizumab Antibody(10E12C6)[Biotin], mAb, Mouse | 0.37 | Direct/Inhibitory ELISA, Detection antibody for pembrolizumab, PK/PD bridging ELISA with A01844 |
| A01846-40 | Anti-Pembrolizumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
| A01960-40 | MonoRab™ Anti-Pembrolizumab Antibody (90G12), mAb, Rabbit? | 0.38 | Direct/Inhibitory ELISA, Detection antibody for pembrolizumab, PK/PD bridging ELISA with A01852 |
| A01853-40 | MonoRab™ Anti-Pembrolizumab Antibody(90G12F8)[Biotin], mAb, Rabbit | 0.38 | Direct/Inhibitory ELISA, Detection antibody for pembrolizumab, PK/PD bridging ELISA with A01852 |
抗雷珠單抗（Anti-Ranibizumab/Lucentis, 靶向VEGF)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02035-40 | Anti-Ranibizumab Antibody (6C3), mAb, Mouse | 0.85 | Direct/Indirect/Inhibitory ELISA, Capture antibody for Ranibizumab, PK/PD bridging ELISA with A02036-40 |
| A02036-40 | Anti-Ranibizumab Antibody (10D12), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Obinutuzumab, PK/PD bridging ELISA with A01945-40 |
| A02037-40 | Anti-Ranibizumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗利妥昔單抗（Anti-Rituximab，靶向CD20）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01969-40 | Anti-Rituximab Antibody (6C1), mAb, Mouse | N/A | Indirect ELISA, Capture antibody for Rituximab, PK/PD bridging ELISA with A01970-40 |
| A01970-40 | Anti-Rituximab Antibody (17B6), mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Rituximab, PK/PD bridging ELISA with A01969-40 |
| A01971-40 | Anti-Rituximab Antibody (17B6)[Biotin], mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Rituximab, PK/PD bridging ELISA with A01969-40 |
| A01918-40 | Anti-Rituximab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
| A01942-40 | MonoRab™ Anti-Rituximab Antibody (137C6), mAb, Rabbit | N/A | Indirect ELISA, Capture antibody for Rituximab, PK/PD bridging ELISA with A01943-40 |
| A01943-40 | MonoRab™ Anti-Rituximab Antibody (194D7), mAb, Rabbit | N/A | Direct/Indirect ELISA, Detection antibody for Rituximab, PK/PD bridging ELISA with A01942-40 |
| A01944-40 | MonoRab™ Anti-Rituximab Antibody (194D7)[Biotin], mAb, Rabbit | N/A | Direct/Indirect ELISA, Detection antibody for Rituximab, PK/PD bridging ELISA with A01942-40 |
抗托株單抗（Anti-Tocilizumab，靶向TNF）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A01978-40 | Anti-Tocilizumab Antibody (14B10), mAb, Mouse | N/A | Indirect/Inhibitory ELISA, Capture antibody for Tocilizumab PK/PD bridging ELISA with A01979-40 |
| A01979-40 | Anti-Tocilizumab Antibody (6C10), mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Tocilizumab, PK/PD bridging ELISA with A01978-40 |
| A01980-40 | Anti-Tocilizumab Antibody (6C10)[Biotin], mAb, Mouse | N/A | Direct/Indirect ELISA, Detection antibody for Tocilizumab, PK/PD bridging ELISA with A01978-40 |
| A01932-40 | Anti-Tocilizumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗曲妥珠單抗（Anti-Trastuzumab/Herceptin, 靶向HER2)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02032-40 | Anti-Trastuzumab Antibody (11C4), mAb, Mouse | N/A | Direct/Indirect ELISA, Capture antibody for Trastuzumab, PK/PD bridging ELISA with A02033-40 |
| A02033-40 | Anti-Trastuzumab Antibody (15H2), mAb, Mouse | N/A | Direct/Indirect/Inhibitory ELISA, Detection antibody for Trastuzumab, PK/PD bridging ELISA with A02032-40? |
抗英夫利昔單抗 （ Anti-Infliximab/Remicade，靶向TNF-α）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02040-40 | Anti-Infliximab Antibody (27A4) , mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Capture antibody for Infliximab, PK/PD bridging ELISA with A02041-40 |
| A02041-40 | Anti-Infliximab Antibody (23H5) , mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Infliximab , PK/PD bridging ELISA with A02040-40 |
抗抗炎藥單抗（Anti-Sarilumab/Kevzara, 靶向IL-6R）
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02042-40 | Anti-Sarilumab Antibody (26B10) , mAb, Mouse | 0.062 | Direct/Indirect/Inhibitory ELISA, Capture antibody for Sarilumab , PK/PD bridging ELISA with A02043-40 |
| A02043-40 | Anti-Sarilumab Antibody (23H12) , mAb, Mouse | 0.056 | Direct/Indirect/Inhibitory ELISA, Detection antibody for Sarilumab, PK/PD bridging ELISA with A02042-40 |
| A02044-40 | Anti-Sarilumab Antibody (20F5), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA |
抗度普利尤單抗(Anti-Dupilumab/Dupixent, 靶向IL-4Rα)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02062-40 | Anti-Dupilumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗帕利珠單抗(Anti-Palivizumab/Synagis, 靶向RSV F)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02064-40 | Anti-Palivizumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗奧馬珠單抗(Anti-Omalizumab/Xolair, 靶向human IgE)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02060-40 | Anti-Omalizumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗依那西普單抗(Anti-Etanercept/Enbrel, 靶向 ?TNF-α)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02113-40 | Anti-Etanercept Antibody (4H1), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Etanercept, PK/PD bridging ELISA with A02114-40 |
| A02114-40 | Anti-Etanercept Antibody (4H5), mAb, Mouse | 0.467 | Direct/Indirect ELISA, Capture antibody for Etanercept, PK/PD bridging ELISA with A02113-40 |
抗戈利木單抗(Anti-Golimumab/Simponi, 靶向 ?TNF-α)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02093-40 | Anti-Golimumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗阿維魯單抗(Anti-Avelumab/Bavencio, 靶向PD-L1)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02120-40 | Anti-Avelumab Antibody (12G9), mAb, Mouse | 0.741 | Direct/Indirect ELISA, Detection antibody for Avelumab, PK/PD bridging ELISA with A02021-40 |
| A02121-40 | Anti-Avelumab Antibody (12H7), mAb, Mouse | 0.748 | Direct/Indirect ELISA, Capture antibody for Avelumab, PK/PD bridging ELISA with A02020-40 |
抗帕尼單抗(Anti-Panitumumab/Vectibix, 靶向 ?EGFR)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02099-40 | Anti-Panitumumab Antibody (2E7), mAb, Mouse | 0.567 | Direct/Indirect ELISA, Detection antibody for Panitumumab, PK/PD bridging ELISA with A02100-40 |
| A02100-40 | Anti-Panitumumab Antibody (9G12), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Panitumumab, PK/PD bridging ELISA with A02100-40 |
| A02063-40 | Anti-Panitumumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗烏司奴單抗(Anti-Ustekinumab/Stelara, 靶向IL-12 & ?IL-23)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02117-40 | Anti-Ustekinumab Antibody (5F9), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Detection antibody for Ustekinumab, PK/PD bridging ELISA with A02118-40 |
| A02118-40 | Anti-Ustekinumab Antibody (9A5), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Capture antibody for Ustekinumab, PK/PD bridging ELISA with A02117-40 |
| A02119-40 | Anti-Ustekinumab Antibody (11E3), mAb, Mouse | 0.5 | Direct/Indirect/Inhibitory ELISA |
| A02123-40 | Anti-Ustekinumab Antibody, pAb, Rabbit | N/A | Direct ELISA, Immunogenicity assay |
抗狄諾塞麥單抗(Anti-Denosumab/Prolia, 靶向 ?RANKL)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02101-40 | Anti-Denosumab Antibody (2H7), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Capture antibody for Denosumab, PK/PD bridging ELISA with A02102-40 |
| A02102-40 | Anti-Denosumab Antibody (9A10), mAb, Mouse | 0.893 | Direct/Indirect ELISA, Detection antibody for Denosumab, PK/PD bridging ELISA with A02101-40 |
抗依庫珠單抗(Anti-Eculizumab/Soliris, 靶向Complement protein C5)
| 產品編號 | 名稱 | 半抑制率 IC50 (μg/ml) | 應用推薦 |
|---|---|---|---|
| A02115-40 | Anti-Eculizumab Antibody (4F6), mAb, Mouse | Non-inhibitory | Direct/Indirect ELISA, Capture antibody for Eculizumab, PK/PD bridging ELISA with A02116-40 |
| A02116-40 | ?Anti-Eculizumab Antibody(13F5), mAb, Mouse | 1.053 | Direct/Indirect ELISA, Detection antibody for Eculizumab, PK/PD bridging ELISA with A02115-40 |
